Interactions of circulating, digoxin-like, steroids with rate control therapy for atrial fibrillation in the RATE-AF randomised clinical trial

Back

ESC Professional Premium Access

Interactions of circulating, digoxin-like, steroids with rate control therapy for atrial fibrillation in the RATE-AF randomised clinical trial

Session: The role of rate control and comorbidities in atrial fibrillation

Topic: Rate Control

Speaker: Doctor I. Akoumianakis (Birmingham, GB)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Doctor Ioannis Akoumianakis

University of Birmingham, Birmingham (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Ranolazine is associated with a reduced incidence of atrial fibrillation in patients with chronic coronary syndrome: the results of a real-world analysis of an Italian population

Speaker: Associate Professor S. Fumagalli (Florence, IT)

High levels of intermediate cd14++cd16+ monocytes predict incident atrial fibrillation in the general population

Speaker: Doctor K. Sveen (Oslo, NO)

The impact of sick sinus syndrome on flow velocity of the left atrial appendage in patients with atrial fibrillation

Speaker: Doctor S. Takahashi (Kobe, JP)

Clinical impact of type 1 and type 2 diabetes mellitus in atrial fibrillation and the effect of severe hypoglycaemia: a nationwide cohort study

Speaker: Professor L. Fauchier (Tours, FR)

Is pre-diabetes a predictor of events in patients with atrial fibrillation?

Speaker: Doctor A. Ledo Pineiro (Vigo, ES)

Access the full session

The role of rate control and comorbidities in atrial fibrillation

Speakers: Doctor I. Akoumianakis, Associate Professor S. Fumagalli, Doctor K. Sveen, Doctor S. Takahashi, Professor L. Fauchier...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources